Veronika Pilchová, Ahmed Elmontaser Mergani, Sabrina Clever, Malgorzata Ciurkiewicz, Kathrin Becker, Ingo Gerhauser, Wolfgang Baumgärtner, Asisa Volz, Maren von Köckritz-Blickwede, Claudia Schulz
Veterinary pathology 2023 Sep 12The SARS-CoV-2 pandemic required the immediate need to transfer inactivated tissue from biosafety level (BSL)-3 to BSL-1 areas to enable downstream analytical methods. No validated SARS-CoV-2 inactivation protocols were available for either formaldehyde (FA)-fixed or glutaraldehyde (GA)-fixed tissues. Therefore, representative tissue from ferrets and hamsters was spiked with 2.2 × 106 tissue culture infectious dose 50% per ml (TCID50/ml) SARS-CoV-2 or were obtained from mice experimentally infected with SARS-CoV-2. SARS-CoV-2 inactivation was demonstrated with 4% FA or 5% GA at room temperature for 72 hours by a titer reduction of up to 103.8 TCID50/ml in different animal tissues with a maximum protein content of 100 µg/mg and a thickness of up to 10 mm for FA and 8 mm for GA. Our protocols can be easily adapted for validating the inactivation of other pathogens to allow for the transfer of biological samples from BSL-3 areas to BSL-1 laboratories.
Veronika Pilchová, Ahmed Elmontaser Mergani, Sabrina Clever, Malgorzata Ciurkiewicz, Kathrin Becker, Ingo Gerhauser, Wolfgang Baumgärtner, Asisa Volz, Maren von Köckritz-Blickwede, Claudia Schulz. SARS-CoV-2 inactivation in laboratory animal tissues with 4% formaldehyde or 5% glutaraldehyde for transfer to biosafety level 1 laboratories. Veterinary pathology. 2023 Sep 12:3009858231197128
PMID: 37698272
View Full Text